Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Book an appointment using our booking tool, or simply give us a call
Patients in these studies achieved an average weight loss of 2022% of body weight over 72 weeks when following the weekly schedule
Retatrutide is a medication from Eli Lilly that is under development for the treatment of type 2 diabetes and obesity
If you fall into any of these buckets, microdosing is unlikely to solve the underlying problem: BMI over 35 with obesity-related conditions (Type 2 diabetes, hypertension, sleep apnea, PCOS) History of bariatric surgery with significant weight regain Plateaued at a microdose for more than 4 to 6 months with no meaningful progress Have tried microdosing twice or more and stopped both times Need to lose more than 50 pounds to reach a healthy weight At BodEvolve Bariatric & Cosmetic Surgery Center, dr Frenzel works with patients across Texas who came in thinking a GLP-1 microdose would be the answer, and left with a clearer plan that actually matched their goals
Patients should be educated about symptoms of hyperglycaemia (increased thirst, frequent urination, fatigue) and hypoglycaemia if taking other diabetes medications
